Slides: SGLT2 inhibition in kidney disease: What are the key lessons from the EMPA-REG OUTCOME trial?
Presentation Prof. Wanner
This lecture by prof. Christoph Wanner part of a CME accredited symposium: Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibition held at ERA-EDTA 2018 in Copenhagen. Slides are available as an educational service to PACE members and meeting participants
View presentation slides
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: